Eisai
4523.T
#2184
Rank
NZ$14.66 B
Marketcap
NZ$51.97
Share price
0.11%
Change (1 day)
3.75%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$6.53 Billion

According to Eisai's latest financial reports the company's total liabilities are NZ$6.53 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31NZ$6.12 B12.17%
2024-03-31NZ$5.45 B3.44%
2023-03-31NZ$5.27 B-4.74%
2022-03-31NZ$5.54 B18.36%
2021-03-31NZ$4.68 B-16.69%
2020-03-31NZ$5.61 B1.45%
2019-03-31NZ$5.53 B-2.03%
2018-03-31NZ$5.65 B3.04%
2017-03-31NZ$5.48 B7.55%
2016-03-31NZ$5.10 B0.92%
2015-03-31NZ$5.05 B1.87%
2014-03-31NZ$4.96 B-24.04%
2013-03-31NZ$6.53 B-23.54%
2012-03-31NZ$8.54 B-14.8%
2011-03-31NZ$10.02 B-2.06%
2010-03-31NZ$10.23 B-19.9%
2009-03-31NZ$12.78 B56.87%
2008-03-31NZ$8.14 B199.31%
2007-03-31NZ$2.72 B-14.87%
2006-03-31NZ$3.19 B20.6%
2005-03-31NZ$2.65 B-6.46%
2004-03-31NZ$2.83 B-9.13%
2003-03-31NZ$3.11 B-1.65%
2002-03-31NZ$3.17 B-21.63%
2001-03-31NZ$4.04 B